New Informatics Solution enables healthcare professionals to more immediately identify, validate and respond to clinical and administrative information
WARRENDALE, Pa., June 3 /PRNewswire/ -- MEDRAD, Inc. has launched Manage.Report, an informatics application that enables healthcare professionals to immediately access clinical and administrative information associated with radiology patients' contrast injections from nearly anywhere. This is the first in the company's series of informatics platform applications, and radiology imaging's premier browser-based informatics solution.
Manage.Report automatically captures and logs in a secure database essential patient and radiology-management information concerning contrast injections delivered by the MEDRAD Stellant(R) CT injector. In addition to meeting the needs of clinical teams through immediate access to patient-specific injection information, Manage.Report automates record keeping, increases data accuracy, simplifies the audit process and facilitates compliance with the Joint Commission. RIS/PACS integration and remote service extensions are under development for the informatics solution, a platform based on service-oriented architecture and flexible design.
"Whether focusing on improved patient care, consistency in outcomes or increasing productivity, Manage.Report removes barriers to accessing the information that evidence-based decision making demands," says Anthony Cinalli, executive director, Radiology Marketing. "Healthcare professionals can identify need and determine the course of action by analyzing robust clinical and administrative data sets they choose to monitor."
Manage.Report automatically captures procedure information in a secure database. Within moments after the scan, radiologists can log in and review details on the actual protocols administered to their patients and consider injection specifics associated with the procedure such as pressure rates and flow graphs. Administrators can track procedure volumes, contrast usage and injection events, and conduct detailed analysis using robust, customized reporting capabilities.
About MEDRAD, Inc.
MEDRAD, Inc. develops, markets and services medical devices used to diagnose and treat disease. Its product offerings include fluid injection systems for radiology and cardiology, endovascular devices for the safe treatment of cardiovascular disease, magnetic resonance-compatible accessories and equipment services. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is a business of Bayer Medical Care. More company information is available at www.medrad.com.
The Bayer Group is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.
Cautionary statement regarding forward-looking statements.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
|SOURCE MEDRAD, Inc.|
Copyright©2009 PR Newswire.
All rights reserved